Tavia Acquisition Corp. SEC filings TAVIR
Tavia Acquisition Corp. has 94 filings in SEC EDGAR's recent list, going back to May 15, 2024. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Current report | Jul 13, 2026 | — |
| EFFECT | Filing | Dec 3, 2024 | — |
| CERT | Filing | Dec 3, 2024 | — |
| 8-A12B | For registration of certain classes | Dec 3, 2024 | — |
| CORRESP | Letter to the SEC | Nov 29, 2024 | — |
| CORRESP | Letter to the SEC | Nov 29, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2024 | — |
| CORRESP | Letter to the SEC | Oct 29, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2024 | — |
| CORRESP | Letter to the SEC | Jun 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2024 | — |
| DRS | Filing | May 15, 2024 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- TAVI (Nasdaq), TAVIR (Nasdaq), TAVIU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Newark, DE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2020385
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.